Home » Topics » Regulatory

Regulatory
RSS

BioMarin's amifampridine phosphate approved in the EU for LEMS

Jan. 7, 2010

Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD

Dec. 4, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

FDA approves Cymbalta for maintenance treatment of GAD

Dec. 1, 2009

Angiox approved in E.U. for additional indication

Dec. 1, 2009

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Shire launches Intuniv in the U.S. for ADHD in children and adolescents

Nov. 9, 2009

FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma

Nov. 9, 2009

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Nov. 6, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...